Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine

NCT05293665 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

944

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Vaccines

Interventions

BIOLOGICAL: UB-612
BIOLOGICAL: BNT162b2 vaccine
BIOLOGICAL: ChAdOx1-S vaccine
BIOLOGICAL: Sinopharm BIBP

Sponsor

Vaxxinity, Inc.

Collaborators

[object Object]
[object Object]